Qube Research & Technologies (QRT)
MGX icon

Qube Research & Technologies (QRT)’s Metagenomi Therapeutics MGX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MGX Stock Details MGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1K Buy
+16,850
New +$22.5K ﹤0.01% 3219
2024
Q3 		– Sell
-1,053
Closed -$4.3K – 4258
2024
Q2 		$4.3K Sell
1,053
-15,614
-94% -$107K ﹤0.01% 3072
2024
Q1 		$176K Buy
+16,667
New +$192K ﹤0.01% 3082

Other funds holding MGX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MGX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Metagenomi Therapeutics (MGX) in Q2 2026: 16,850 shares worth $20.1K. The stake represents ﹤0.01% of the portfolio and ranks #3219 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in MGX as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in MGX in Q1 2024 and has held it in 3 quarters since. The position peaked at $176K in Q1 2024. 43 funds tracked by Wall St. Rank hold MGX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 16,850 shares of Metagenomi Therapeutics worth $20.1K as of Q2 2026.
  • Metagenomi Therapeutics was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Metagenomi Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3219 holding.
  • Qube Research & Technologies (QRT) first reported a position in Metagenomi Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s Metagenomi Therapeutics position peaked at $176K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Metagenomi Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.